methylprednisolone has been researched along with Histiocytosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayyappan, C; Jeyaraman, M; Karthik, SN; Meenakshi-Sundaram, S; Pandi, S; Sankaranarayanan, M | 1 |
| Hounoki, H; Nomoto, K; Shinoda, K; Taki, H; Tobe, K; Tsuda, R | 1 |
| Fukushima, H; Kadota Ji, J; Kiya, T; Kohno, S; Mizukane, R; Nakatomi, M; Yamaguchi, T | 1 |
| Frickhofen, N; Herrmann, F; Köchling, G; Lange, W; Lindemann, A; Mertelsmann, RH; Raghavachar, A; Schrezenmeier, H | 1 |
1 review(s) available for methylprednisolone and Histiocytosis
| Article | Year |
|---|---|
Super refractory status in a case of Febrile Infection-Related Epilepsy Syndrome due to hemophagocytic lymphocytic histiocytosis.
Topics: Adolescent; Anti-Inflammatory Agents; Anticonvulsants; Epileptic Syndromes; Fatal Outcome; Histiocytosis; Humans; Immune System Diseases; Lacosamide; Male; Methylprednisolone; Status Epilepticus | 2021 |
3 other study(ies) available for methylprednisolone and Histiocytosis
| Article | Year |
|---|---|
Cytophagic histiocytic panniculitis in a 74-year-old man.
Topics: Aged; Cyclosporine; Cytophagocytosis; Drug Therapy, Combination; Gallium Radioisotopes; Glucocorticoids; Histiocytosis; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Panniculitis; Prednisolone; Treatment Outcome; Whole Body Imaging | 2013 |
An elderly patient with hemophagocytic syndrome due to severe mycoplasma pneumonia with marked hypercytokinemia.
Topics: Aged; Bone Marrow; Drug Therapy, Combination; Erythromycin; Follow-Up Studies; Histiocytosis; Humans; Male; Methylprednisolone; Multiple Organ Failure; Pneumonia, Mycoplasma; Respiratory Insufficiency; Risk Assessment; Severity of Illness Index; Syndrome; Thrombocytopenia | 2002 |
Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Cyclosporine; Drug Therapy, Combination; Histiocytosis; Humans; Interleukin-3; Male; Methylprednisolone; Recombinant Proteins | 1991 |